SC66 is primarily utilized in biomedical research, particularly in the study of cancer and cellular signaling pathways. It is known for its role as an inhibitor of the Akt signaling pathway, which is crucial in regulating cell survival, growth, and metabolism. By targeting Akt, SC66 helps researchers understand the mechanisms of cancer cell proliferation and resistance to apoptosis. This compound is also used in preclinical studies to evaluate its potential as a therapeutic agent in various cancer types, including breast, lung, and prostate cancers. Additionally, SC66 aids in exploring the effects of Akt inhibition on tumor growth and metastasis, contributing to the development of targeted cancer therapies.